Clinical Trials Browser

Phase 2 × Pancreatic Adenocarcinoma Locally Advanced × Electroporation × Clear all

NCT07306273 2025-12-29

IRE Combined With the Dual-Function Antibody PD-1/CTLA-4 for the Treatment of LAPC Following Failure of First-Line AG Therapy

Phase 2 Recruiting

Gastrointestinal

Pancreatic Adenocarcinoma Locally Advanced